Clinical trials
Other Cancer clinical trials
Below are recruiting other cancer clinical trials, each written for real people, not researchers. We’re tracking 12,892 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07475806RecruitingPhase 2
Bladder-sparing drug combo for muscle-invasive bladder cancer
This study tests two drugs, enfortumab vedotin and pembrolizumab, to see if they can help people with muscle-invasive bladder cancer avoid removing their bladder. The drugs are given before the standard surgery to possibly shrink the tumor and improve outcomes.
Little Rock, ArkansasAges 18 years+ - NCT04689802Recruiting
Study urine tests to help screen for cancer
This study looks for a new set of urine “markers” (measurable substances in urine) that may help detect cancer earlier. If you join, they will collect your urine and compare results between people with cancer and people without cancer.
ShatinAges 18 years+ - NCT03914391Recruiting
Find new urine tests to screen for prostate cancer
This study looks for new urine markers (signals) that could help screen for prostate cancer. If you have a higher PSA blood test and are scheduled for a prostate biopsy, your urine sample may be studied to see if it can improve screening.
ShatinAges 18 years+ - NCT07808151RecruitingPhase 2
Immunotherapy before surgery for colon cancer
This trial tests a combination of two immunotherapy drugs (pembrolizumab and porustobart) given before surgery for colon cancer that can be removed. The goal is to see if this treatment can help shrink the tumor and improve outcomes.
Los Angeles, CaliforniaAges 18 years+ - NCT07085442Recruiting
Audit of targeted lymph node biopsy for early breast cancer
This study looks at how well a special type of lymph node biopsy works for people with early breast cancer that has spread to a small number of lymph nodes. It aims to see if this approach is effective and safe, which may help guide future treatment decisions.
BurnleyAges 18 years+ - NCT06568939RecruitingPhase 2
Study of telisotuzumab vedotin for non-squamous lung cancer
This trial tests a drug called telisotuzumab vedotin (ABBV-399) given through a vein to people with a specific type of advanced lung cancer (non-squamous non-small cell lung cancer) that has a high level of a protein called c-Met. The study aims to see how the drug affects the body and helps control the cancer.
Chandler, ArizonaAges 18 years+ - NCT07111520RecruitingPhase 1/Phase 2
Combination treatment for advanced lung cancer
This trial tests two investigational drugs, BNT326 and BNT327, together in people with advanced non-small cell lung cancer (NSCLC) that has spread or can't be cured with local treatment. The goal is to see if the combination is safe and might help shrink tumors.
Los Angeles, CaliforniaAges 18 years+ - NCT07466212Recruiting
Quality of life for cancer patients with diabetes on immunotherapy
This study looks at how immunotherapy affects the quality of life of cancer patients who also have diabetes. It aims to understand and improve their overall well-being during treatment.
AalborgAges 18 years+ - NCT05997615RecruitingPhase 1
New targeted treatment for advanced prostate cancer
This trial tests a new medicine that targets prostate cancer cells with a 'smart bomb' approach. It might be an option for patients whose cancer has progressed despite other treatments.
Duarte, CaliforniaAges 18 years+ - NCT07885475Recruiting
Study of dexmedetomidine for hard-to-treat cancer pain
This study tests a medication called dexmedetomidine for people with advanced cancer who have severe pain that is not relieved by usual pain medicines. Dexmedetomidine is a sedative that may help control pain when other options don't work.
DrammenAges 18 years+ - NCT07885423Recruiting
PET and fluorescent imaging for prostate cancer surgery
This trial tests a new imaging agent that may help surgeons see prostate cancer more clearly during surgery, potentially leading to more complete removal of the cancer. You may be eligible if you are scheduled for prostate cancer surgery and have not had prior treatment for your cancer.
Xiamen, FujianAges 18 years+ - NCT06802991Recruiting
Nutrition and support after colon cancer surgery for older patients
This trial tests a carefully planned program of nutrition and follow-up support for older patients after colon cancer surgery. It aims to help you recover better and avoid problems after you go home.
HerlevAges Any age - NCT05168566RecruitingPhase 2
Sutetinib for advanced lung cancer with uncommon EGFR mutations
This trial tests a new pill called Sutetinib for people with advanced non-small cell lung cancer that has certain uncommon EGFR mutations. It aims to see if the drug can shrink tumors and help patients live longer.
Glendale, CaliforniaAges 18 years+ - NCT05911217RecruitingPhase 1
Study of CT041 after chemotherapy for pancreatic cancer
This trial tests a new treatment called CT041, which uses your own immune cells to target a protein on cancer cells, after standard chemotherapy and surgery. It aims to see if it can prevent the cancer from coming back.
Beijing, Beijing MunicipalityAges 18–79 - NCT07886229RecruitingPhase 1
Propranolol and toripalimab before surgery for lung cancer
This trial tests whether adding a beta-blocker (propranolol) and an immunotherapy drug (toripalimab) to standard chemotherapy can help shrink tumors before surgery in people with early-stage but advanced lung cancer. The goal is to improve surgery outcomes and reduce the chance of cancer coming back.
Changsha, HunanAges 18–75 - NCT07886047RecruitingPhase 1
Propranolol, immunotherpy, and chemotherapy for small cell lung cancer
This trial tests a combination of a blood pressure medicine (propranolol), an immunotherapy drug (adebrelimab), and standard chemotherapy for patients with extensive-stage small cell lung cancer. The goal is to see if this combo helps control the cancer better than chemotherapy alone.
Changsha, HunanAges 18–75 - NCT05468554RecruitingPhase 3
Metformin for fertility during thyroid cancer treatment
This study tests whether the drug metformin, which is commonly used for diabetes, can help protect fertility in women who receive radioactive iodine (I-131) for thyroid cancer. If you join, you might take metformin during your treatment, and the researchers will monitor your fertility.
BialystokAges 18–45 - NCT06686394RecruitingPhase 1/Phase 2
Patritumab deruxtecan combinations for advanced HER2-positive breast cancer
This trial tests a new drug, patritumab deruxtecan, combined with other anti-cancer drugs for people with HER2-positive breast cancer that has spread or cannot be removed by surgery. It aims to see if these combinations can shrink tumors or slow cancer growth.
Aurora, ColoradoAges 18 years+ - NCT05099172RecruitingPhase 1/Phase 2
Targeted therapy for advanced lung cancer with EGFR or HER2 changes
This trial tests a new targeted drug for people with advanced non-small cell lung cancer that has specific genetic changes (EGFR or HER2). The drug may slow cancer growth and help you live longer.
Gilbert, ArizonaAges 18 years+ - NCT07680439RecruitingPhase 2
CAR T cell therapy study for children with DIPG brain tumor
This trial tests a new CAR T cell therapy (BCB-276) for children and young adults with a type of brain tumor called DIPG. The therapy uses your own immune cells that are specially trained to attack the cancer.
Los Angeles, CaliforniaAges 1–26 - NCT06822348Recruiting
Osteopathic therapy for heart health in lung cancer patients
This study tests whether gentle osteopathic manipulations can improve heart rate variability (a measure of heart health) in people with stage 4 lung cancer who are starting chemotherapy for the first time. It may help understand if this therapy can support heart function during cancer treatment.
AvignonAges 18 years+ - NCT07659795RecruitingPhase 2
Study of VS-7375 for KRAS G12D colorectal cancer
This trial tests a new targeted pill, VS-7375, for people with a specific type of advanced colorectal cancer called KRAS G12D. It's for those who either haven't had treatment yet or whose cancer has worsened after prior therapy.
Scottsdale, ArizonaAges 18 years+ - NCT06565260Recruiting
Exercise and nutrition program for cancer survivors and caregivers
This study offers a community-based program of exercise and nutrition classes for cancer survivors and their caregivers. It aims to help improve health and well-being after cancer treatment.
Buffalo, New YorkAges 18 years+ - NCT07658183RecruitingPhase 2
Different doses of an injection for advanced breast cancer
This trial tests a new drug called BL0175 to see if it helps postmenopausal women with advanced breast cancer that has stopped responding to hormone therapy. The drug is given as an injection, and the study compares different doses to find the safest and most effective one.
Shanghai, Shanghai MunicipalityAges 18 years+
Hear when a new Other Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for other cancer?
- Yes. Clin2 currently lists 12,892 recruiting other cancer studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a other cancer trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a other cancer trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.